Top Story

Integrated health care may eliminate racial disparities in colon cancer survival

January 26, 2015

Providing fair, high-quality, evidence-based care can eliminate racial disparities in survival outcomes among patients with colon cancer, according to results of a retrospective study.

Survival rates between black patients and white patients with colon cancer have been observed for the past 2 decades. However, data suggest those disparities may be the result of treatment quality and not patient factors such as race, according to study background.

Breaking News

FDA approves Triferic for iron replacement in patients with chronic kidney disease

January 26, 2015
The FDA today approved Triferic to treat iron loss in patients with chronic kidney disease who are on dialysis, according to the drug’s manufacturer.Triferic…
Mikkael A. Sekeres In the Journals

Azacitidine, lenalidomide treatment appears safe for myelodysplastic syndrome, AML

January 26, 2015
A sequential treatment combination of lenalidomide and azacitidine appeared active in and safe for patients with high-risk myelodysplastic syndrome or acute myeloid…
FDA approvals

FDA grants orphan drug status to ovarian cancer treatment

January 26, 2015
The FDA granted orphan drug designation to liposomal encapsulated paclitaxel, or LEP-ETU, an ovarian cancer treatment in development by Insys Therapeutics Inc., the…
In the Journals

Majority of PCPs assigned high value to medical imaging

January 26, 2015
The majority of primary care physicians considered access to medical imaging to be essential to patient care, indicating that it aided in establishing earlier and more…
More News Headlines »
Stem Cell Transplant for AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
Meeting News Coverage Video
Genome editing demonstrated wide application for blood disorders

Genome editing demonstrated wide application for blood disorders

January 4, 2015
SAN FRANCISCO — Ralph Green, MD, PhD, FRCPath, medical director of the UC Davis Health System Medical…
More »
Activity cover

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »